Skip to main content

Evommune, Inc 8-K, filed Nov 5, 2026

Evommune, Inc. (EVMN)

8-K 2026-11-05 For: 2026-11-05
View Original
Added on November 05, 2026

About this 8-K

Evommune, Inc filed this 8-K on November 5, 2026.

Evommune made a pre-recorded webcast available at 8:30 a.m. ET on November 5, 2026, covering EVO570’s preclinical profile, planned rheumatoid arthritis development path and Hinova Pharmaceuticals Inc. license terms. AI summary

Items reported

  • Item 7.01: Regulation FD disclosure
  • Item 9.01: Financial statements and exhibits